We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Drug Discovery

Drug Discovery

Stay up to date on the topics that matter to you

AMSBIO

AMSBIO is recognized today as a leading transatlantic company contributing to the acceleration of discovery through the provision of cutting-edge life science technology, products and services for research and development in the medical, nutrition, cosmetics and energy industries.

Latest AMSBIO Content

Efficient direct translocation of proteins into living cells using BioPORTER® protein delivery reagent.

Direct Translocation of Proteins Into Living Cells

BioPORTER® protein delivery reagent from AMSBIO is proven to efficiently transport functionally active proteins directly into living cells eliminating the traditional DNA transfection, transcription, and protein translation process.

Iinduced Pluripotent Stem Cells Derived Neurons stained using CellO-IF technology.

Immunofluorescent Staining Within Hours, Not Days

AMSBIO has launched CellO-IF – an all-in-one immunofluorescent staining reagent kit designed to accelerate the labelling organoids and spheroids directly in hydrogels or extracellular matrices.

Viral particles.

Tailor Made Transduction-Ready Viral Particles

AMSBIO offers a production service for high quality custom transduction-ready viral particles designed to support your research and save you valuable time.

A close up of an individual holding a 96- well plate.

Sensitive Detection of Cell Culture Mycoplasma Infection

The MycoScope™ Mycoplasma PCR detection kit from AMSBIO uses polymerase chain reaction (PCR) technology to detect mycoplasma infections in less than 3 hours.

Staining images of ACE2-expressing iPS cells.

Culture Techniques for Drug Discovery and Therapeutics

AMSBIO has published an informative online article that reviews the importance of culture techniques for induced pluripotent stem cells (iPSCs), which provide an invaluable resource for drug discovery and therapeutic applications.

iPSC colonies.

Genetically Engineered iPSCs Offer Improved Efficiency and Cost Savings

AMSBIO has launched a range of genetically engineered Induced Pluripotent Stem Cells (iPSCs) developed to provide improved model fidelity over cell lines and biochemical assays used for drug discovery and cell therapy research.

Cells.

GLP-1R Reporter Cell Line for Diabetes / Obesity Research

AMSBIO has launched a Glucagon-Like Peptide 1 Receptor (GLP-1R) reporter cell line.

Cultured meat – a new era in food technology.

Products for Sustainable Food Development

AMSBIO offers a range of kits, media and reagents enabling development of food in a way that is not wasteful of our natural resources and is not detrimental to the environment or consumer health.

GMP compliant products and services.

GMP Compliant Materials and Support for ATMP Manufacturing

AMSBIO is dedicated to helping its customers seamlessly translate their cutting-edge research into production products for clinical therapy. A comprehensive new resource has been added to the website.

A close up of someone holding a small bottle.

GMP Collagen Type I Additive for Reinforcing Bioprinted Constructs

Produced using dry-spun 50 µm Collagen Type I fibers, AMSBIO has introduced the innovative CollaFibR™ additive proven to increase the shape fidelity and biological relevance of bioprinted constructs in hydrogels and bioinks.

Advertisement

Advertisement

Decoratvive background images

Never miss a story

with the Breaking Science News daily newsletter